Linden Advisors’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Linden Advisors’s Portfolio TDACW Stock Details TDACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.87M	Buy	1,317,931 +1,017,932	+339%	+$1.02M	0.01%	357
2026 Q1	$44.3K	Hold	299,999	–	–	﹤0.01%	513
2025 Q4	$84.6K	Hold	299,999	–	–	﹤0.01%	413
2025 Q3	$96K	Hold	299,999	–	–	﹤0.01%	347
2025 Q2	$92.5K	Hold	299,999	–	–	﹤0.01%	321
2025 Q1	$76.6K	Buy	+299,999	New	+$52.8K	﹤0.01%	249

Other funds holding TDACW

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Linden Advisors's TDACW Position: Q2 2026 in Review

Linden Advisors increased its Translational Development Acquisition Corp Warrants (TDACW) stake by 339% in Q2 2026, buying an estimated $1.02M and bringing the position to 1,317,931 shares worth $1.87M. The position accounts for 0.01% of the portfolio, ranked #357.

Linden Advisors first reported a position in TDACW in Q1 2025 and has held it in 6 quarters since. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.

Linden Advisors held 1,317,931 shares of Translational Development Acquisition Corp Warrants worth $1.87M as of Q2 2026.
Linden Advisors bought 1,017,932 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $1.02M.
Translational Development Acquisition Corp Warrants made up 0.01% of Linden Advisors's portfolio in Q2 2026, its #357 holding.
Linden Advisors first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 6 quarters since.
28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on Linden Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.